Literature DB >> 30418556

Regional Body Fat Changes and Metabolic Complications in Children With Dunnigan Lipodystrophy-Causing LMNA Variants.

Nivedita Patni1, Xilong Li2, Beverley Adams-Huet2, Chandna Vasandani3, Rita A Gomez-Diaz4, Abhimanyu Garg3.   

Abstract

CONTEXT: Familial partial lipodystrophy, Dunnigan variety (FPLD2) is a rare autosomal-dominant disorder due to heterozygous missense lamin A/C (LMNA) mutations. Subjects with FPLD2 gradually lose fat from the upper and lower extremities but gain fat in the face and neck around puberty. However, the precise onset of body fat changes and metabolic complications during childhood remains unknown.
OBJECTIVE: To compare metabolic parameters and regional body fat in children with FPLD2 with the sex- and age-matched controls from the National Health and Nutrition Examination Survey (NHANES) 2005 to 2010.
METHODS: We measured fasting serum triglycerides, glucose, and skinfold thicknesses in all children (aged 1 to 18 years) harboring FPLD2-causing LMNA mutations and determined regional body fat by dual-energy X-ray absorptiometry in those aged ≥8 years.
RESULTS: Thirty-two affected females and 14 males participated. The lower limb fat in all affected females, except one, was below or equal to the first percentile and in two affected males was below the fifth percentile for NHANES. One female subject with FPLD2 followed from age 6 to 16 years revealed marked loss of extremity fat much before thelarche. Serum triglycerides were higher in females with FPLD2 aged 7 to 18 years compared with controls (median 208 vs 70 mg/dL; P < 0.0001) and showed inverse correlation with extremity skinfolds. Serum triglycerides in males with FPLD2 were not significantly different than controls.
CONCLUSIONS: The onset of fat loss from the extremities, especially in girls with FPLD2, occurs well before the onset of puberty. High serum triglycerides are seen in young females with FPLD2 with severe loss of fat from the extremities.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30418556      PMCID: PMC6382455          DOI: 10.1210/jc.2018-01922

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Efficacy of Metreleptin Treatment in Familial Partial Lipodystrophy Due to PPARG vs LMNA Pathogenic Variants.

Authors:  Hilal Sekizkardes; Elaine Cochran; Noemi Malandrino; Abhimanyu Garg; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2019-08-01       Impact factor: 5.958

2.  Circulating Levels of MiRNAs From 320 Family in Subjects With Lipodystrophy: Disclosing Novel Signatures of the Disease.

Authors:  Alessia Dattilo; Giovanni Ceccarini; Gaia Scabia; Silvia Magno; Lara Quintino; Caterina Pelosini; Guido Salvetti; Roberto Cusano; Matteo Massidda; Lucia Montanelli; Donatella Gilio; Gianluca Gatti; Alessandro Giacomina; Mario Costa; Ferruccio Santini; Margherita Maffei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-06       Impact factor: 6.055

3.  Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety.

Authors:  Chandna Vasandani; Xilong Li; Hilal Sekizkardes; Beverley Adams-Huet; Rebecca J Brown; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

Review 4.  Familial Partial Lipodystrophy (FPLD): Recent Insights.

Authors:  Christos Bagias; Angeliki Xiarchou; Alexandra Bargiota; Stelios Tigas
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-06       Impact factor: 3.168

5.  Dunnigan lipodystrophy syndrome: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins).

Authors:  H Mosbah; B Donadille; M C Vantyghem; C Vigouroux; C Vatier; S Janmaat; M Atlan; C Badens; P Barat; S Béliard; J Beltrand; R Ben Yaou; E Bismuth; F Boccara; B Cariou; M Chaouat; G Charriot; S Christin-Maitre; M De Kerdanet; B Delemer; E Disse; N Dubois; B Eymard; B Fève; O Lascols; P Mathurin; E Nobécourt; A Poujol-Robert; G Prevost; P Richard; J Sellam; I Tauveron; D Treboz; B Vergès; V Vermot-Desroches; K Wahbi; I Jéru
Journal:  Orphanet J Rare Dis       Date:  2022-04-19       Impact factor: 4.303

Review 6.  Importance of the Microenvironment and Mechanosensing in Adipose Tissue Biology.

Authors:  Simon Lecoutre; Mélanie Lambert; Krzysztof Drygalski; Isabelle Dugail; Salwan Maqdasy; Mathieu Hautefeuille; Karine Clément
Journal:  Cells       Date:  2022-07-27       Impact factor: 7.666

7.  Lamin A/C Is Dispensable to Mechanical Repression of Adipogenesis.

Authors:  Matthew Goelzer; Amel Dudakovic; Melis Olcum; Buer Sen; Engin Ozcivici; Janet Rubin; Andre J van Wijnen; Gunes Uzer
Journal:  Int J Mol Sci       Date:  2021-06-19       Impact factor: 5.923

8.  Multisystem Progeroid Syndrome With Lipodystrophy, Cardiomyopathy, and Nephropathy Due to an LMNA p.R349W Variant.

Authors:  Iram Hussain; Ruilin Raelene Jin; Howard B A Baum; Jerry R Greenfield; Sophie Devery; Chao Xing; Robert A Hegele; Barbara G Carranza-Leon; Macrae F Linton; Frank Vuitch; Kathy H C Wu; Débora Rossi Precioso; Junko Oshima; Anil K Agarwal; Abhimanyu Garg
Journal:  J Endocr Soc       Date:  2020-07-27

9.  Approach to Diagnosing a Pediatric Patient With Severe Insulin Resistance in Low- or Middle-income Countries.

Authors:  Alise A van Heerwaarde; Renz C W Klomberg; Conny M A van Ravenswaaij-Arts; Hans Kristian Ploos van Amstel; Aartie Toekoen; Fariza Jessurun; Abhimanyu Garg; Daniëlle C M van der Kaay
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.